The profound increase in number of pharmaceutical and biotech start-ups has contributed to the development of Israel’s life science industry. Also, the Israel government has been offering enormous support to biopharmaceutical industry in recent years to increase investments in the R&D activities. Also, sufficient investments, venture capital funds, and availability of skilled & diverse workforce are some of the other factors driving the market growth.
Download PDF Brochure @ http://www.micromarketmonitor.com/contact/3847633375-download_pdf_brochure.html
However, stringent governmental regulations for drug pricing work against the market growth of the Israel bio-pharma research market.
Speak to Analyst @ http://www.micromarketmonitor.com/contact/3847633375-speak_to_analyst.html
In-depth profiling of the key players has been conducted, along with the recording of the recent developments and strategies adopted by the key players to sustain and strengthen their positions in the Israel bio-pharma research market. Thermo Fisher Scientific Inc. (U.S.), Merck KGAA (Germany), Perkinelmer Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.). are among the key players engaged in this market.
